About this event
- Date and time Thu 30 Oct 2025 from 8:00am to 31 Oct 2025 at 5:05pm
- Location Royal Society of Medicine
- Organised by Partner Symposium, Cleveland Clinic London
Cardiovascular disease (CVD) is the leading cause of death worldwide, highlighting the need for better education to improve care and outcomes.
Stay at the forefront of CVD with our two-day seminar bringing together experts from the UK and the US for a state-of-the-art review of the most significant changes, critical updates, and recommendations to incorporate into your practice. Attendees can expect updates on cutting-edge science and the implementation of evidence-based guidelines, with the opportunity to network with fellow attendees and renowned speakers. In partnership with the Cleveland Clinic’s Heart, Vascular and Thoracic Institute.
Topic highlights include:
- Prevention and management of CVD
- Essentials of CAD
- Heart failure and cardiomyopathies
- Heart rhythm
- Diagnosis and management decisions in valve disease
This conference aims to:
- Apply knowledge to reduce cardiovascular risks through optimal management of dyslipidemia, hypertension, and diabetes.
- Describe innovations in diagnostic modalities and their clinical use to screen, diagnose, and treat patients with cardiovascular disease.
- Evaluate medical and procedural options for prevention, detection, risk assessment, rhythm and rate management, and stroke prevention in the care of patients with atrial fibrillation.
- Analyse the evidence on traditional and contemporary pharmacotherapies, monitoring, and therapeutic devices, to prioritize treatment in heart failure management.
- Evaluate special considerations in heart failure care, including cardio-oncology, cardiogenic shock, critical care cardiology, cardio-obstetrics, cardiometabolic considerations, and cardiac amyloidosis and HOCM.
- Demonstrate comprehensive, evidence-based care in the evaluation and management of ischemic heart disease.
- Utilise recent evidence on mitral and aortic valve disease and diseases of the aorta in clinical decision making for patients with structural heart disease.
Target Audience
This event is specifically tailored for General Practitioners, Consultant Cardiologists, Cardiac Surgeons, nurses, and other medical professionals involved in managing cardiovascular disease patients. Due to limited availability, we kindly request that only individuals from these professions register.
Accreditation
In support of improving patient care, the Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
American Medical Association (AMA)
Cleveland Clinic Center for Continuing Education has approved this live activity for AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Certificate of Participation
A certificate of participation will be provided to other healthcare professionals for requesting credits in accordance with their professional boards and/or associations.
Faculty Disclosure
The Cleveland Clinic Foundation Center for Continuing Education has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Integrity and Independence requiring mitigation of all faculty conflicts of interest. Faculty declaring a relevant financial relationship will be identified in the activity syllabus.
Cleveland Clinic is nationally ranked and globally recognised as a world leader in cardiovascular care.
Sponsorship and exhibit
For exhibiting or sponsoring this event, please contact Milena Kachar by emailing [email protected]
Follow us on:
Agenda
Day 1: View the programme 30 October 2025
Registration, Tea and Coffee
Welcome and Introduction
Lars Svensson & Olaf Wendler
Session 1: Prevention of cardiovascular disease
Chairs: Leslie Cho & Bernard Prendergast
Panelists: Ruth Whitby, Simon Hodes, Erica Tirr & Michael Papadakis
Case scenario: Clinical presentation and initial assessment
Lucy Hepburn
Lipoprotein(a): New frontiers in risk reduction
Leslie Cho
Beyond statins: Alternative lipid lowering therapies to manage residual risk
Michael Papadakis
The asymptomatic patient with a high coronary calcium score: What next?
Milind Desai
The double jeopardy of diabetes and obesity: SGLT2i, GLP1RA or both?
Barbara McGowan
Old and evolving strategies for treatment-resistant hypertension
Ian Webb
Case scenario: Management strategy and clinical outcome
Lucy Hepburn
Panel Discussion - Audience Q&A
Tea and coffee break
Session 2 – Cardiovascular disease in specific patient subsets
Chairs: Christine Jellis & Mike Bellamy
Panelists: Narbeh Melikian, Roy Jogiya, Luna Siddique & Nick Sawyer
Case scenario: Clinical presentation and initial assessment
Erin Jackson
Hormone therapy and the heart: Debunking myths, embracing evidence
Luna Siddique
Geriatric cardiology: Management of cardiovascular disease in elderly co-morbid patients
Amanda Vest
Cardio-oncology: Screening and key management considerations
Sanjeev Bhattacharya
Cardio-rheumatology: An emerging epidemic coming soon to a clinic near you
Taryn Youngstein
Sports cardiology: Screening of professionals (and wanabees) and prevention of sudden death
Aneil Malhotra
Cardio-obstetrics: Common problems and their management
Leslie Cho
Case scenario: Management strategy and clinical outcome
Erin Jackson
Panel discussion and Q&A
Lunch
Session 3: The essentials of ischaemic heart disease
Chairs: Ed Soltesz & Ian Webb
Panelists: Matt Faircloth, Narbeh Melikian, Mrinal Saha & Cesare Quarto
Case scenario: Clinical presentation and initial assessment
Mackenzie Smith
Advanced multimodality imaging in ischaemic heart disease
Christine Jellis
Revascularization for stable angina and silent ischaemia: Current thinking
Matt Faircloth
Acute coronary syndromes: Pills, PCI and pitfalls
Mrinal Saha
Ischaemic heart failure: Advanced strategies, revascularisation and circulatory support
Ed Soltesz
Cardiac rehabilitation: Who, how and when?
Leslie Cho
Case scenario: Management strategy and clinical outcome
Mackenzie Smith
Panel discussion and Q&A
Tea and coffee break
Session 4: Cardiomyopathies and heart failure
Chairs: Amanda Vest & George Amin-Yousseff
Panelists: Brian Halliday, Sameer Patel, Anthony Li & Sanjay Sharma
Case scenario: Clinical presentation and initial assessment
Natasha Anno-Barnieh
Initiation and optimisation of guideline-directed medical therapy
Amanda Vest
Heart failure with preserved ejection fraction: Emerging aetiologies and treatments
Guy Lloyd
Hypertrophic cardiomyopathy: New diagnostic and therapeutic approaches
Milind Desai
Cardiogenic shock: Coronary care, intensive care and team-based networks
Ed Soltesz
Ablation of arrhythmias in heart failure: What can the electrophysiologist provide?
Oussama Wazni
Case scenario: Management strategy and clinical outcome
Natasha Anno-Barnieh
Panel discussion and Q&A
Close
Drinks reception
Day 2: View the programme 31 October 2025
Registration, Tea and Coffee
Welcome and announcements
Session 5: Heart rhythm management
Chairs: Oussama Wazni & Pier Lambiase
Panelists: Matt Wright, Anthony Li, Manav Sohal & Tom Wong
Case scenario: Clinical presentation and initial assessment
Sandra Varghese
Screening for atrial fibrillation: Who, when and how?
Sabine Ernst (Virtual)
Combined AF ablation and left atrial appendage closure: Future directions for stroke prevention
Oussama Wazni
Ablation of ventricular arrhythmias: New approaches and emerging technologies
Anthony Li
New frontiers in pacing: Lead-related complications and use of leadless devices
Aldo Rinaldi
Cardiac syncope: Diagnosis, investigation and treatment
Manav Sohal
Case scenario: Management strategy and clinical outcome
Sandra Varghese
Panel discussion and Q&A
Tea and coffee break
Session 6: Valve disease I – Diagnosis and surveillance
Chairs: Marc Gillinov & Bernard Prendergast
Panelists: Mike Bellamy, Brian Griffin, Guy Lloyd & Kelly Victor
Case scenario: Clinical presentation and initial assessment
Kelly Victor
The new ESC guidelines on valve disease – key messages for clinical practice
Bushra Rana
Echocardiographic assessment of valve disease: A career’s worth of tips and tricks
Brian Griffin
Earlier intervention for aortic stenosis: Emerging evidence and clinical practice
Milind Desai
Patient selection for mitral and tricuspid valve intervention: What does the referrer need to know?
Jonathan Byrne
Multiple valve disease: Which high risk combinations need referral – and when?
Sanjeev Battacharya
Case scenario: Management strategy and clinical outcome
Kelly Victor
Panel discussion and Q&A
Lunch
Session 7: Valve disease II – Transcatheter intervention and surgery
Chairs: Simon Redwood & Samir Kapadia
Panelists: Roberto Casula, Max Baghai, Sam Dawkins & Bernard Prendergast
Case scenario: Clinical presentation and initial assessment
Vitaliy Androshchuk
Transcatheter aortic valve implantation: Innovation and evolution
Chris Cook
Lifetime management of aortic stenosis: The remaining role of surgery
Olaf Wendler
Modern mitral valve surgery: Staying ahead of the game
Marc Gillinov
Transcatheter mitral and tricuspid valve intervention: Where are we and where are we going?
Samir Kapadia
Beyond valve disease: Further offerings from the structural interventionist
Sam Dawkins
Case scenario: Management strategy and clinical outcome
Vitaliy Androshchuk
Panel discussion and Q&A
Tea and coffee break
Session 8: Complex aortic and peripheral vascular disease
Chairs: Olaf Wendler & Lars Svensson
Panelists: Aung Oo, Jason Wilkins, Gianluca Lucchese & Chung Lim
Case scenario: Clinical presentation and initial assessment
Jessica Bivand
Screening and surveillance of peripheral arterial and venous disease: diagnosis, medical therapy and referral for surgery
Chung Lim
Thoracic aortopathy with or without valve disease: Optimal assessment with multimodality imaging
Milind Desai
Advances in aortic valve and root surgery: TAVI is not always the answer!
Lars Svensson
Vascular surgery below the diaphragm: Expanding indications and collaborative working
Mark Tyrell
Beyond surgery: Interventional and hybrid approaches
Ed Soltesz
Case scenario: Management strategy and clinical outcome
Erin Jackson
Panel discussion and Q&A
Closing remarks
Lars Svensson & Olaf Wendler
Close of meeting
Location
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Disclaimers:
Registration for this event will close on 29 October 2025 at 8:00pm (BST). Late registrations will not be accepted.
The agenda is subject to change at any time
All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.